Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan L Mendoza

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Journal of Bioenergetics and Biomembranes|December 15, 2007
Building an understanding of cystic fibrosis on the foundation of ABC transporter structuresJuan L Mendoza, Philip J Thomas
Methods in Molecular Biology (Clifton, N.J.)|May 20, 2011
Introduction to section IV: biophysical methods to approach CFTR structureJuan L Mendoza, André Schmidt, Philip J Thomas
Methods in Molecular Biology (Clifton, N.J.)|May 20, 2011
Biochemical and biophysical approaches to probe CFTR structureAndré Schmidt, Juan L Mendoza, Philip J Thomas
The Journal of Biological Chemistry|September 24, 2010
A unique redox-sensing sensor II motif in TorsinA plays a critical role in nucleotide and partner bindingLi Zhu, Linda Millen, Juan L Mendoza, et al.
Advances in Immunology|January 7, 2014
Multifarious determinants of cytokine receptor signaling specificityIgnacio Moraga, Jamie Spangler, Juan L Mendoza, et al.
Trends in Biochemical Sciences|October 14, 2022
Recent and future perspectives on engineering interferons and other cytokines as therapeuticsTheint Aung, William S Grubbe, Rebecca J Nusbaum, et al.
Annual Review of Immunology|December 11, 2014
Insights into cytokine-receptor interactions from cytokine engineeringJamie B Spangler, Ignacio Moraga, Juan L Mendoza, et al.
Current Opinion in Immunology|April 12, 2024
Structure-function of type I and III interferonsNicole A de Weerd, Aleksandra K Kurowska, Juan L Mendoza, et al.
World Journal of Gastroenterology|August 2, 2014
Need for infliximab dose intensification in Crohn's disease and ulcerative colitisCarlos Taxonera, David Olivares, Juan L Mendoza, et al.
Cell|January 30, 2016
Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic OutcomesCherie T Ng, Juan L Mendoza, K Christopher Garcia, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Journal of Bioenergetics and Biomembranes|December 15, 2007
Building an understanding of cystic fibrosis on the foundation of ABC transporter structuresJuan L Mendoza, Philip J Thomas
Methods in Molecular Biology (Clifton, N.J.)|May 20, 2011
Introduction to section IV: biophysical methods to approach CFTR structureJuan L Mendoza, André Schmidt, Philip J Thomas
Methods in Molecular Biology (Clifton, N.J.)|May 20, 2011
Biochemical and biophysical approaches to probe CFTR structureAndré Schmidt, Juan L Mendoza, Philip J Thomas
The Journal of Biological Chemistry|September 24, 2010
A unique redox-sensing sensor II motif in TorsinA plays a critical role in nucleotide and partner bindingLi Zhu, Linda Millen, Juan L Mendoza, et al.
Advances in Immunology|January 7, 2014
Multifarious determinants of cytokine receptor signaling specificityIgnacio Moraga, Jamie Spangler, Juan L Mendoza, et al.
Trends in Biochemical Sciences|October 14, 2022
Recent and future perspectives on engineering interferons and other cytokines as therapeuticsTheint Aung, William S Grubbe, Rebecca J Nusbaum, et al.
Annual Review of Immunology|December 11, 2014
Insights into cytokine-receptor interactions from cytokine engineeringJamie B Spangler, Ignacio Moraga, Juan L Mendoza, et al.
Current Opinion in Immunology|April 12, 2024
Structure-function of type I and III interferonsNicole A de Weerd, Aleksandra K Kurowska, Juan L Mendoza, et al.
World Journal of Gastroenterology|August 2, 2014
Need for infliximab dose intensification in Crohn's disease and ulcerative colitisCarlos Taxonera, David Olivares, Juan L Mendoza, et al.
Cell|January 30, 2016
Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic OutcomesCherie T Ng, Juan L Mendoza, K Christopher Garcia, et al.
Pageof 6